🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
1,063

Quick answer

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Metformin

    BRIGHT MINDS BIOSCIENCES INC.

    Systemic Inflammation

    approved small molecule active

    1 trial

  2. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule active

    3 trials

  3. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    approved small molecule completed

    1 trial

  4. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

  5. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Carboxylesterase 1 (CES1) Genotype

    approved small molecule completed

    2 trials

  6. Minocycline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial

  7. Morphine

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    approved small molecule terminated

    1 trial

  8. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    approved small molecule completed

    1 trial

  9. Nicotine Nasal Spray

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  10. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    3 trials

  11. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule terminated

    3 trials

  12. Nicotine patch - transdermal

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  13. OOPEN+BBCC

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Overdose

    approved small molecule completed

    1 trial

  14. Oral Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    HIV-1-infection

    approved small molecule completed

    1 trial

  15. Oral consumption

    BRIGHT MINDS BIOSCIENCES INC.

    Growth Acceleration

    approved other completed

    1 trial

  16. Oxycodone

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Low Back Pain

    approved small molecule completed

    1 trial

  17. Pegylated Interferon

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  18. Pfizer-BioNTech mRNA COVID-19 vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    COVID -19

    approved small molecule active

    1 trial

  19. Pharmacist Practice Change to Dispense Appropriate Opioid Quantities for Acute Pain

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    approved small molecule completed

    1 trial

  20. Pharmacotherapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule completed

    1 trial

  21. Pharmacotherapy for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  22. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    approved small molecule completed

    1 trial

  23. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  24. Prograf

    BRIGHT MINDS BIOSCIENCES INC.

    Renal Transplant Rejection

    approved small molecule completed

    1 trial

  25. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    approved small molecule active

    1 trial

  26. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    1 trial

  27. Quetiapine and placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Disorder

    approved small molecule completed

    1 trial

  28. Regional Anesthesia

    BRIGHT MINDS BIOSCIENCES INC.

    Inguinal Hernia

    approved small molecule completed

    1 trial

  29. Reinforcement Based Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    approved other completed

    1 trial

  30. Scheduled Gradual Reduction + Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    approved other terminated

    1 trial

  31. Short Cycle Antiretroviral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other completed

    1 trial

  32. Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]

    BRIGHT MINDS BIOSCIENCES INC.

    HEPATITIS C (HCV)

    approved small molecule active

    1 trial

  33. Sofosbuvir/velpatasvir (Epclusa®)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  34. Standard clinical care first, followed by standard clinical care and varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved small molecule completed

    1 trial

  35. Stimulant or sedative

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  36. Thoracic epidural (ropivicaine, fentanyl)

    BRIGHT MINDS BIOSCIENCES INC.

    Pectus Excavatum

    approved small molecule completed

    1 trial

  37. Transdermal Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule terminated

    1 trial

  38. Transdermal nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  39. Vaccination to prevent hepatitis B virus infection

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B

    approved mab completed

    1 trial

  40. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    2 trials

  41. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    3 trials

  42. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Parkinson's Disease

    approved small molecule terminated

    1 trial

  43. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule terminated

    1 trial

  44. Video directly observed therapy with contingency management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other active

    1 trial

  45. Web-based smoking cessation program

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved other completed

    1 trial

  46. XR-B (SUBLOCADETM)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule completed

    1 trial

  47. Xinnaoning Capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Stable Angina Pectoris

    approved small molecule active

    1 trial

  48. brand name metoprolol ER

    BRIGHT MINDS BIOSCIENCES INC.

    Blood Pressure

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.